Efficacy and Safety of Electrical Versus Pharmacological Cardioversion in Early Atrial Fibrillation
Not Applicable
Completed
- Conditions
- Atrial Fibrillation
- Interventions
- Procedure: electrical cardioversion
- Registration Number
- NCT00933634
- Lead Sponsor
- Valduce Hospital
- Brief Summary
The optimal strategy to restore sinus rhythm in patients with atrial fibrillation (AF) of less than 48 hours' duration is still controversial. The investigators performed a controlled single-center trial to compare electrical and pharmacological (propafenone) cardioversion to restore the sinus rhythm in selected patients with acute atrial fibrillation.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 247
Inclusion Criteria
- atrial fibrillation of less than 48 hours' duration.
Exclusion Criteria
- AF of more than 48 hours'
- hemodynamic instability
- acute onset atrial fibrillation due to acute coronary syndrome
- electrolyte disturbances
- sepsis
- fever
- hypothermia
- untreated hyperthyroidism
- use of antiarrhythmic drugs
- high embolic risk
- unclear duration of symptoms
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description electrical cardioversion electrical cardioversion Patients were sedated with propofol and external cardioversion was performed in anteroposterior position (right sternal body at the third intercostal space-angle of the left scapula). Patients were submitted to a biphasic wave-form sequential shock of 100-150-200 J, if necessary. propafenone propafenone Propafenone (2 mg/kg bolus) was administered iv to obtain pharmacologic sinus rhythm conversion.
- Primary Outcome Measures
Name Time Method Efficacy of intervention (Electrical and pharmacological cardioversion) in restoring sinus rythm during emergency department stay
- Secondary Outcome Measures
Name Time Method Number of adverse events related to electrical and pharmacological cardioversion during emergency department stay recurrence of atrial fibrillation within 2 months
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie propafenone's efficacy in acute atrial fibrillation cardioversion?
How does electrical cardioversion compare to pharmacological cardioversion with propafenone in early AF patients?
Which biomarkers predict successful pharmacological cardioversion in acute atrial fibrillation cases?
What are the adverse event profiles of propafenone versus electrical cardioversion for early AF?
Are there combination therapies involving propafenone and other antiarrhythmics for atrial fibrillation?
Trial Locations
- Locations (1)
Emergency Unit - Valduce Hospital
🇮🇹Como, Italy
Emergency Unit - Valduce Hospital🇮🇹Como, Italy